INTRODUCTION
Proteins are transported from the ER to the cell surface through a series of membrane-bound compartments. In the case of endoplasmic reticulum (ER) to Golgi transport, specific carrier vesicles have been shown to mediate membrane traffic at this stage of the secretory pathway. Two soluble yeast gene products, SEC18 and SEC17, have been implicated in vesicle fusion (Wilson et al., 1989; Griff et al., 1992) . SEC18, which was originally identified as a gene whose product is required for vesicular transport between the ER and Golgi complex (Novick et al., 1980) , also plays a role in intraGolgi and post-Golgi membrane traffic events (Graham and Emr, 1991) . The mammalian homologue of SEC18 is the N-ethylmaleimide-sensitive factor (NSF; Wilson et al., 1989) , a cytosolic protein that mediates the fusion of vesicles with their acceptor compartment (Malhotra et al., 1988) . The association of NSF with membranes is dependent upon the presence of three soluble NSF attachment proteins (a, ,B, and y SNAPs) vesicles and not on other compartments. This interaction, which appears to facilitate the activity of Boslp, is catalyzed by Yptlp (Lian et al., 1994) . Based on these data it was proposed that Yptlp, and other small GTP-binding proteins, regulate the specificity of vesicular transport by selectively activating the v-SNARE on vesicles.
In an effort to identify additional components that may functionally interact with this group of proteins, we have used the betl-l mutant in a synthetic lethal screen. Synthetic lethality results when the effect of combining two mutations in the same haploid strain causes cell death under growth conditions that are permissive for either single mutant. Thus, the combined effect of both mutations impairs a specific process to a greater extent than either one alone. Here we report the use of such a screen to identify a new temperature-sensitive (ts) secretory mutant that is blocked in ER to Golgi transport, bet3-1. Like BETI, BET3 interacts genetically with BOSi, SEC21, SEC22, YPT1, and encodes an essential hydrophilic 22-kDa protein that is highly homologous to a Caenorhabditis elegans protein (p20) of unknown function. Studies presented here suggest that Bet3p functions before the pairing of the v-SNARE with its t-SNARE.
MATERIALS AND METHODS Mutant Isolation and Screen
SFNY185 was grown to early exponential phase at 25°C to obtain 5 x 107 cells/ml. Cells were washed twice with sterile water, resuspended in 0.1 M sodium phosphate buffer (pH 7.0) and mutagenized with 3% ethylmethanesulfonate (-70% killing). After shaking for 1 h at 30°C, the cells were washed with sterile water, transferred to a new tube, and washed two more times with 5% sodium thiosulfate. Afterward, the cells were allowed to recover during a 20-h incubation at 25°C in 100 ml of YPD medium (total OD599 of 25.5). Cells were centrifuged, resuspended in fresh YPD medium, and then shifted to 37°C for 3 h. Subsequent to this shift the cells were washed, resuspended in 0.5 ml of water, and layered onto a 12.5-ml Percoll gradient (90% Percoll prepared in yeast nitrogen base without amino acids) in a Beckman Quickseal centrifuge tube (16 x 76 mm; Fullerton, CA). The tubes were heatsealed and spun at 22,000 x g for 20 min at 4°C in a Beckman ultracentrifuge (TI50 rotor). Fractions (the densest 0.8-2.6% of the cells) were collected (1.0 ml) using an ISCO fraction collector, diluted 2 x 10-4 in sterile water, and 0.2 ml was plated onto selective plates that were grown for 3 days at 25°C as described previously (Novick et al., 1980; Finger and Novick, 1992 Trans- label. Cells were then washed with cold 10 mM sodium azide and resuspended in 1 ml of spheroplast buffer (1.4 M sorbitol, 50 mM potassium phosphate, pH 7.5, 10 mM sodium azide, 50 mM f3-mercaptoethanol, 10 jig of zymolyase/l OD unit of cells). Spheroplasts were formed during a 60-min incubation at 37°C and then lysed in 1 ml of lysis buffer (10 mM triethanolamine, pH 7.2, 1 mM EDTA, 0.8 M sorbitol, and 1 x protease inhibitor cocktail; Ruohola et al., 1988) .
The unbroken cells were removed during a 3-min spin at 450 x g, and the resulting supematant was heated for 5 min at 100°C in the presence of SDS (1% final concentration). Samples (100 ,ul) were diluted with 900 ,lI of PBS in 1% Triton X-100 and centrifuged for 15 min in an Eppendorf microfuge. The supernatant was removed and incubated overnight on ice with one of the following antibodies: 2 t,l of anti-invertase, 6 ,ul of anti-a-factor, or 2 ,ul of anti-carboxypeptidase Y. Immune complexes were precipitated onto protein A-Sepharose beads (30 ,ul of a 10% solution/,ul of antibody) during a 90-min incubation at 4'C. The beads were washed twice with urea wash buffer (2 M urea, 200 mM NaCl, 100 mM Tris, pH 7.6, 1% Triton X-100), then twice with 1% 3-mercaptoethanol, and the contents of the beads were solubilized in 70 ,ul of Laemmli sample buffer.
Polyclonal anti-Bet3p antibody was raised to a Bet3p-MBP fusion protein that was purified according to manufacturer's directions (New England Biolabs, Beverly, MA). The immunization protocol was described previously (Louvard et al., 1982) and the serum was affinity purified on a column containing cross-linked Bet3p-GST fusion protein. To precipitate Bet3p, approximately 7 OD units of cells were resuspended in fresh medium to an OD599 = 3.00 and labeled at 24°C for 45 min with 0.7 mCi (200 ,Ci/ml) of 35S In Vitro label. The protocol used was the same as described above with minor modifications. Spheroplasts were lysed in 0.7 ml of buffer (10 mM Tris, pH 8.0, 25 mM EDTA, pH 8.0, and 1% SDS) and then heated to 100°C for 5 min before they were diluted 1:20 in IP buffer (10 mM Tris, pH 8.0, 150 mM sodium chloride, 0.1 mM ethylenediaminetetraacetic acid, and 0.5% Tween). The diluted lysates were incubated with either 5 ,ul of pre-immune serum, 5 ,ul of anti-Bet3p antibody, or 5 .tg/ml of affinity-purified anti-Bet3p polyclonal antibody. The immune complexes were precipitated with protein ASepharose and the beads were washed twice with IP buffer, twice with IP buffer containing 2 M urea, and twice with 1% 13-mercaptoethanol.
All samples were subjected to SDS electrophoresis (12.5% 
Genetic Techniques and Constructions
The BET3 gene was cloned by complementation of the growth defect of the bet3-1 mutant. The mutant was transformed with a high copy plasmid library (Carlson and Botstein, 1982) Maniatis et al. (1989) . Plasmids used in this study ( Figure 5 ) were constructed as follows. The original isolate pGR1 contained a 14.9-kb insert. Plasmid pGR3 was obtained by subcloning pGR1 as a 5.2-kb Sall-Sall fragment into the Sall site in the polylinker of pRS426 (Christianson et al., 1992) or the polylinker of pRS306 to yield pGR2. Plasmid pGR4 was constructed in an identical fashion except that the Sall-SalI fragment was inserted into the Sall site in the polylinker of pRS316 (Christianson et al., 1992) . To isolate pGR5, the 2.6-kb SaiI-KpnI insert from pGR4 was inserted into the KpnISall sites of pRS316. Plasmid pGR6 was constructed by inserting the 1-kb KpnI-PvuII fragment from pGR4 into the KpnI-SmaI sites in the polylinker region of pRS316. To isolate pGR7, pGR1 was digested with PvuII and the vector was religated. Plasmid pGR8 was constructed by subcloning the 1.55-kb XbaI-XbaI fragment from pGR5 into the XbaI site in the polylinker of pRS315.
To place the BET3 gene under the control of the regulatable GALl promoter, polymerase chain reaction (PCR) was used to introduce restriction sites at the amino and carboxy terminus of BET3. A BamHI site was placed two amino acids upstream from the start methionine of BET3, while an EcoRI site was introduced at the C-terminus of the gene. The PCR product was digested with BamHI and EcoRI before it was subcloned into the BamHI/EcoRI sites in the polylinker of pNB527. The resulting plasmid (pGR10) was linearized with ClaI and integrated into SFNY314 at the LEU2 locus.
To disrupt BET3, the KpnI-SaiI fragment shown in Figure 5 , was first subcloned into a bluescript M13 vector in which the HindIII site was destroyed. The BET3 gene was then excised from this subclone, by digesting the plasmid with HindIII, and replaced with a HindIIIHindlIl fragment that contains the selectable marker URA3. The SaII-KpnI fragment was excised, transformed into NY1060, and tetrad analysis was performed.
The Bet3p-MBP fusion protein was constructed by introducing a BamHI site two amino acids upstream from the start methionine of BET3 using PCR. A BamHI-HindIII fragment was then introduced into the polylinker site of pPR734 placing BET3 in-frame with the 3' end of the malE gene to yield pGR18. The Bet3-GST fusion protein was constructed (pGR20) by introducing a BamHI site two amino acids from the start methionine of BET3 using PCR. An EcoRI site was also introduced after the stop codon of BET3 by PCR. The BamHI-EcoRI fragment was then subcloned into the BamHI-EcoRI sites of pGEX three times, placing the BET3 gene in-frame with GST.
DNA Sequence Analysis and Homology Search
To sequence the SaII-KpnI fragment that contains BET3, the 1.6-kb SaiI-PvuII fragment and the 1-kb PvuII-KpnI fragment were subcloned into sequencing vectors for single strand DNA sequencing. The 1.6-kb SalI-PvuII fragment was digested from pGR3 and inserted into the SmaI-SalI sites in the polylinker of pUC118 and pUC119 (Vieira and Messing, 1987) . The 1-kb PvuII-KpnI insert was subcloned into the same vectors using the HincII-KpnI sites of the polylinker. The DNA sequence was determined by the method of Sanger et al. (1977) using the Sequenase version 2 DNA sequencing kit. The BET3 sequence was compared with other sequences by searching databases with the TFASTA program.
Enzyme Assays and Other Procedures
Whole cell invertase assays were performed as described by Goldstein and Lampen (1975) ; the units of activity are reported as micromoles of glucose released per minute per OD599 of cells. Internal invertase was assayed as described earlier (Newman and FerroNovick, 1987) .
Samples were prepared for electron microscopy using a modification of protocols described previously (Newman and Ferro-Novick, 1987) . Briefly, early log phase cells that were grown in YPD medium were shifted for 2 h at 37°C. The cells were washed in 0.1 M cacodylate buffer (pH 6.8), fixed in buffer A (0.1 M cacodylate buffer, pH 6.8, 3% glutaraldehyde) for 1 h at room temperature, and then resuspended in fresh buffer A before they were incubated overnight at 4°C. Fixed cells were washed in 50 mM potassium phosphate (pH 7.5) and converted to spheroplasts in buffer B (50 mM potassium phosphate, pH 7.5, 0.25 mg/ml of Zymolyase lOOT) during a 40-min incubation at 37°C. The spheroplasts were washed twice with ice cold 0.1 M cacodylate buffer and post-fixed for 1 h at 4°C in 0.1 M cacodylate buffer with 2% osmium tetroxide. The pellet was washed three times with distilled water and then treated with a 2% uranyl acetate solution for 1 h at room temperature. The samples were washed twice in water, dehydrated with ethanol, pre-embedded in a 1:1 mixture of acetone with spurr resin, and embedded in spurr resin. Thin sections (60-80 nm) were cut, stained with uranyl acetate and lead citrate, and analyzed with a JEOL-UEM-10 CX II) electron microscope at 80 kV.
RESULTS
Isolation of bet3-1 To identify new genes whose defective products are lethal in combination with BETI, a betl-l mutant strain (SFNY185 ; Table 1 ), that harbors BETI on a CEN plasmid (pAN102) was mutagenized with ethylmethanesulfonate. Because the enrichment of dense cells leads to the selection of a higher percentage of secretory mutants, we used a density enrichment protocol in our screen (Novick et al., 1980 ; see MATERIAL MATala, GAL/GAL, 112 Vol. 6, December 1995 1771 AND METHODS). Of the 21,800 colonies analyzed, 2,120 were temperature sensitive (ts) for growth at 37°C. These mutants were tested for their ability to lose the BETI-containing plasmid (pAN102) on 5-FOA plates. 5-FOA is converted to a toxic compound (5-fluorouracil) by the product of the URA3 gene (orotidine-5'-phosphate decarboxylase). In the presence of 5-FOA, ura3 (but not URA3) cells will grow. Of the 2,120 ts colonies that were tested on these plates, 66 failed to grow at 25°C. The remaining strains were assayed for defects in the secretion of invertase, a glycoprotein that is transported into the yeast periplasm (Goldstein and Lampen, 1975 Linkage studies and plasmid complementation analysis were performed with the remaining mutants to determine whether any were defective in previously identified genes whose products have been implicated in secretion. These studies indicated that ts 44 was allelic with sec22, while five other mutants (ts 14, 20a, 40, 60 , and 75) harbored mutations in three known sec genes (sec3, sec4, and secl7). These strains, as well as the remaining mutants, were mated to wild-type cells. Further genetic analysis was performed by displacing plasmid pAN102 and sporulating the diploid cells. The betl-1 mutation was then separated from the newly identified ts mutation during tetrad analysis. Only one mutant, ts29, was found to be defective in a gene that is lethal in combination with betl-1. In contrast, the sec3, sec4, and secl7 alleles that were identified by this selection were not lethal with betl, suggesting that their isolation was fortuitous. The remaining five mutants that accumulated invertase did not harbor mutations that were lethal in combination with betl-1.
To determine whether the defect in ts29 was due to one mutation, this strain was crossed to wild type, sporulated, and subjected to tetrad analysis. Of the 50 tetrads examined, the growth defect segregated 2:2 in all cases, indicating that it was due to a single ts mutation. Furthermore, the secretion defect co-segregated with the growth defect in three of the tetrads examined. To demonstrate that ts29 is lethal in combination with betl-1, we crossed one of the ts colonies to betl-l and performed tetrad analysis. Twelve tetrads were examined. In each case, the double mutants were inviable (see Table 3 ), demonstrating that ts29 is defective in a new gene whose product interacts genetically with BET1. We called this new mutant bet3-1. Subsequent analysis of bet3 was performed with a strain that was backcrossed twice to wild type.
The Secretion of Invertase Is Rapidly Blocked in bet3-1 upon a Shift to 37°C Our analysis of invertase indicated that this marker protein failed to be transported to the periplasm at 37°C (Table 2) , although transit appeared to be normal (our unpublished results) at the permissive temperature (24°C). If BET3 plays a direct role in secretion, then cells harboring a mutation in this gene should rapidly block the export of invertase after a shift to the restrictive temperature. To assess the speed at which the bet3 mutant phenotype is expressed at 37°C, cells were first incubated for 35 min at 25°C in low glucose-containing medium to derepress the synthesis of invertase. Mutant cells were then shifted to 37°C and internal and external levels of the enzyme were measured at various timepoints. We found that active invertase accumulated within the bet3-1 mutant 5 min after it was incubated at its restrictive temperature ( Figure 1A ). Fur- The bet3-1 Mutant Pleiotropically Blocks the Transit of Proteins from the ER to the Golgi Complex ed upon a snhtt A prediction of the synthetic lethal screen that we employed is that bet3 should be defective in ER to Golgi transport. Because the precursor form of a protein that accumulates intracellularly is indicative of the stage at which transport is blocked (Novick et al., 1981; Newman and Ferro-Novick, 1987) , we radiolabeled yeast cells during the derepression of invertase and examined the form that is retained within the cell (Carlson and Botstein, 1982) . The secreted form of 370C invertase is initially synthesized as a 62-kDa protein.
In the lumen of the ER, the signal sequence is cleaved and 9-10 N-linked oligosaccharide units are added to invertase to yield an -80-kDa species. As has been shown for betl-l (Newman and Ferro-Novick, 1987) -250C and other ER-accumulating mutants, such as secl8-1 (Novick et al., 1981 ; see control in Figure To determine the extent to which the 80-kDa form of invertase is reversibly secreted, bet3-1 mutant cells were first shifted to 37°C in low glucose-containing medium to accumulate precursor intracellularly (Table 2). Subsequent to this incubation, the cells were shifted to 24°C for 3 h in the presence of cycloheximide, a drug that inhibits further protein synthesis. To control for the leakage of accumulated enzyme, a par-250C allel experiment was performed at 370C (our unpublished results). The data in Table 2 indicates that the bet3-1 mutant secreted invertase upon a shift to the permissive temperature. The secretion of invertase was greater at 240C than 37°C, indicating that the defect in transport was partially reversible.
Transport of the yeast pheromone a-factor and the vacuolar protease carboxypeptidase Y (CPY) were also 370C examined in bet3-1. a-Factor is synthesized as a 19-kDa precursor that is converted to a 26-kDa species in the lumen of the ER. The 26-kDa ER form of a-factor accumulates in the betl-1, secl8-1 (Newman and Ferro-Novick, 1987 ; Figure 2B , lanes 3 and 4), and bet3-1 mutants at 370C (Figure 2B, compare (Figure 3 , compare A and B) and some small vesicles (average size -60 nm) were found to accumulate in the cytoplasm ( Figure 3B ). The lumen of the ER was dilated and sometimes the nucleus appeared to be multi-lobed. The betl-l mutant also accumulates small vesicles at 37°C. These vesicles are comparable in size to the vesicles that accumulate in secl7, secl8, sec22 (Novick et al., 1980) , and Boslpdepleted cells (Shim et al., 1991) . Thus, the bet3-1 mutant is phenotypically similar to betl-l at its restrictive growth temperature (Newman and Ferro-Novick, 1987) . In addition to small vesicles, bet3-1 also accumulated a number of large vesicles (average size -110 nm). Vesicles of this size have been seen before in secretory mutants that disrupt post-Golgi secretion (Novick et al., 1980) . Both small and large vesicles accumulate in bet2-1 and secl9-1, two mutants that function at more than one stage of the yeast secretory pathway (Newman and Ferro-Novick, 1987; Rossi et al., 1991; Garrett et al., 1994 (Figure 4 ). In contrast, it was difficult to transform the bet3-1 mutant with the SEC21 gene on a multicopy plasmid. However, when transformants were obtained, they grew slower than the parent strain (our unpublished results). Thus, the overproduction of either of these genes enhances or inhibits the growth of the bet3-1 mutant, suggesting that they interact with BET3. In support of these findings, we have also found that the following haploid double mutant combinations were inviable at 25°C: bet3-1 and betl-1; bet3-1 and sec21-1; bet3-1 and sec22-3; and bet3-1 and yptl-3 (see Table 3 ). A ts mutant in bosl was not available for this analysis. These synthetic lethal interactions are specific as mutations in two genes (secl3-1 and secl6-2), whose products are required for vesicle budding, are not lethal in combination with betl-1. Because thin section electron microscopy has revealed that the bet3-1 mutant accumulates both small and large vesicles (Figure 3) , the BET3 gene product may function at more than one stage of the yeast secretory pathway. To explore this possibility further, we crossed the mutant to three ER-accumulating mutants, seci7-1, seci8-1, and secl9-1 that have been proposed to function at multiple stages of the pathway, as well as several post-Golgi mutants (sec2-41, sec4-8, sec8-9, and sec9-4). This analysis has shown that haploid double mutants containing bet3-1 and secl7-1, bet3-1 and secl8-1, bet3-1 and sec2-41, and bet3-1 and sec4-8 were either sick or inviable at 25°C. Thus, these genetic studies support the morphological Cloning the BET3 Gene To clone a wild-type copy of the BET3 gene, the bet3-1 mutant (SFNY316) was transformed with a library of yeast genomic inserts (Carlson and Botstein, 1982) cloned into a high copy vector, YEp24. Of the 30,000 colonies screened, seven grew at 37°C. Plasmids recovered from six of these strains fully complemented the growth defect of bet3-1 at 37°C. The analysis of these six plasmids defined a common 5.2-kb Sall-Sall fragment (pGR4 in Figure 5 ). To determine whether this insert contained the BET3 structural gene, an integration experiment was performed. The 5.2-kb SallSall fragment was subcloned into an integrating vector (pGR2) and digested with KpnI to direct integration into the genome of the bet3-1 mutant (SFNY316). This event placed URA3 adjacent to the cloned gene. The resulting strain was backcrossed to wild type (NY179) and the diploid was sporulated. Of the 16 tetrads examined, the Ts' colonies were always Ura+, demonstrating that the cloned locus was tightly linked to BET3.
Subcloning studies (see Figure 5 ) revealed that BET3 was contained within a smaller 2.6-kb SalI-KpnI fragment (pGR5). When this region was further subcloned to a 1-kb PvuIL-KpnI fragment (pGR6), there was a loss of complementing activity. Furthermore, when the 3.6-kb region to the right of the PvuIl site was deleted from pGR4 (see Figure 5) , activity was also abolished. Thus, the 1.6-kb SalI-PvuII fragment (pGR7) was not sufficient to complement the growth defect of the bet3-1 mutant. Based on these subcloning studies, we conclude that the PvuII site is contained within the BET3 gene. In support of this proposal, we have shown that the 1.55-kb XbaI-XbaI fragment (pGR8 in Figure 5 ), which contains this PvuII site, is sufficient to completely restore growth to bet3-1 at 37°C.
Nucleotide Sequence of the BET3 Gene As a first step toward determining the function of BET3, we cloned and sequenced the gene that encodes this protein. Because the PvuII site described above is contained within BET3, we subcloned the SalI-PvuII (1.6 kb) and PvuII-KpnI (1 kb) fragments into the pUC118 and pUC119 vectors and sequenced to the left and right of the PvuII site. This analysis revealed that one open reading frame spans the PvuII site. The sequence of the -0.6-kb HindIll-HindIll fragment, which contains this open reading frame, is located on chromosome XI (accession number Z28292-4; Dujon et al., 1994) . A search of the data bank revealed that BET3 is 36.4% identical and 60% similar to a 20-kDa (p20) nematode protein (accession number P34605) of unknown function (Figure 6 ), indicating that homologues of Bet3p can be found in a variety of organisms.
To confirm that the identified open reading frame encodes BET3, its ability to complement the growth defect of the bet3-1 mutant was tested. This was done by cloning the open reading frame behind the regulatable GALI promoter. Transcription from this promoter is repressed in the presence of glucose, but not galactose. The resulting plasmid (pGR10 in Figure 5 ) was integrated at the LEU2 locus of SFNY314 (see Table 1 ) and two Leu+ transformants were tested for their ability to grow on plates containing galactose or glucose. These transformants only grew on YP galactose plates at 37°C, confirming that the HindIII-HindIll fragment that we sequenced encodes the BET3 gene. . . . , . > > I > w Z i . 
BET3 Encodes a 22-kDa Protein
The nucleotide sequence of BET3 predicts a hydrophilic protein of 22-kDa with a net negative charge of 6.9 at neutral pH. To confirm the size of Bet3p, polyclonal antibody was raised to a Bet3p-MBP fusion protein.
Lysates prepared from cells that were radiolabeled by the protocol described in MATERIALS AND METHODS were precipitated with pre-immune serum (Figure 7 , lane 1 and 2) or a-Bet3p (Figure 7 , lane 3). This analysis revealed that a-Bet3p recognizes a 22-kDa band, which was also overproduced in a strain that overproduces Bet3p (Figure 7 , lanes 4 and 6). Affinity-purified a-Bet3p cross-reacted with the same protein species (Figure 7, lane 5) . A c-myctagged version of Bet3p, of approximately the same molecular weight, was also recognized by this antibody (our unpublished results).
The SNARE Complex Does Not Form in bet3-1 Mutant Cells Genetic and morphological studies imply that Bet3p may play a role in the late stages of ER to Golgi transport. With antibody in hand, we directly tested the possibility that Bet3p is a component of the SNARE complex. When vesicle fusion is blocked at 37°C in secl8 mutant cells, the SNARE complex accumulates. This complex has been immunoisolated from detergent extracts of secl8 with affinity-purified antiBoslp antibody (Sogaard et al., 1994) . It contains the t-SNARE, which is proposed to be Sed5p, the from the secl8-1 mutant extract ( Figure 8B , lane 2), but not from wild type ( Figure 8B, lane 1) or the bet3-1 extract ( Figure 8B, lane 3) . Thus, the SNARE complex fails to form in bet3-1 mutant cells. Furthermore, the Boslp/Sec22p complex, which accumulates in secretory mutants that are blocked in vesicle targeting and fusion (Lian et al., 1994) were grown in YPD medium to early log phase. Cells were converted to spheroplasts at 25'C using protocols described previously (Ruohola et al., 1988) and the spheroplasts were regenerated for 1 h at 37'C. Regenerated spheroplasts were lysed, and processed as described elsewhere (Lian et al., 1994 Figure 8B , compare lanes 1 and 3 with lane 2). The formation of the Boslp/Sec22p complex correlates with the ability of Boslp to pair with Sed5p (Lian et al. 1994 ).
DISCUSSION
Here we report the use of a synthetic lethal screen to identify an additional gene whose defective product is lethal in combination with betl-1. This analysis has resulted in the isolation of bet3-1, a new ts yeast secretory mutant that fails to transport proteins from the ER to the Golgi complex at 37°C. The phenotypic consequences of mutations in bet3-1 are similar to those that have been observed previously for betl-1. Furthermore, like BETI, BET3 displays genetic interactions with BOSi, SEC21, SEC22, and YPT1. Thus, Bet3p may act in conjunction with Betlp to mediate the same step in ER to Golgi transport. Although BET3 interacts genetically with a group of genes whose products are components of the SNARE complex, the Bet3 protein is not physically associated with this complex. Furthermore, the Boslp/Sec22p complex, as well as the SNARE complex, does not accumulate in bet3-1 mutant cells. These findings support the hypothesis that Bet3p acts upstream of this docking/fusion complex. A clue to the role of Bet3p has come from studies with Betlp and Boslp. Boslp specifically functions on vesicles where it forms a complex with Sec22p, a protein that modulates its activity (Lian and Ferro-Novick, 1993; Lian et al., 1994) . These interactions are catalyzed by the ras-like GTP-binding protein Yptlp. Betlp may interact with Boslp on the ER before Boslp associates with Sec22p on vesicles. Thus, it is possible that Yptlp stimulates the formation of the Boslp/Sec22p complex through Betlp, and Bet3p may act in concert with it. An analysis of Bet3p in an in vitro reaction that reconstitutes transport from the ER to the Golgi complex (Ruohola et al., 1988; Groesch et al., 1990) will enable us to address this possibility.
Two findings suggest that Bet3p may function at more than one stage of the secretory pathway. First, a morphological analysis of bet3-1 has revealed that small (mean size -60 nm) and larger (average size -110 nm) vesicles accumulate in this mutant at 37°C. The larger vesicles are similar to those seen previously in mutants that are blocked in post-Golgi transport (Novick et al., 1980) . Second, genetic studies have revealed that bet3-1 is lethal in combination with sec2-41 or sec4-8, two mutants that are defective in the fusion of post-Golgi transport vesicles with the plasma membrane (Novick et al., 1980) . A prediction of these observations is that BET3 may encode a soluble protein that functions in both ER to Golgi and post-Golgi transport. In support of this hypothesis is the finding that BET3 encodes a highly conserved 22-kDa hydrophilic protein. Further characterization of Bet3p will allow us to determine whether this protein and its homologues function at more than one stage of the secretory pathway in yeast and higher cells.
The findings described here have shown that synthetic lethal screens can be used to isolate secretory mutants that are phenotypically related to each other. The advantage of such a screen is that it facilitates the identification of physically interacting components, or gene products that function on the same or parallel pathways. Now that we have demonstrated that this approach will lead to the isolation of new bet mutants, we are currently using similar screens to find additional genes whose products functionally interact with Boslp and Sec22p.
